Economic Burden of Clostridium difficile Infection in European Countries.

Area of Science:

• Infectious Diseases
• Health Economics
• Public Health

Background:

• Clostridium difficile infection (CDI) is a major global healthcare challenge.
• Estimating the economic burden of CDI in Europe is crucial but complex.
• Existing studies show wide variations in reported costs due to differing methodologies.

Purpose of the Study:

• To assess the economic burden of healthcare facility-associated CDI in Europe.
• To explore the economic impact of recurrent, community-acquired, pediatric, and outbreak-related CDI.
• To provide a comprehensive overview of CDI's financial impact on European healthcare systems.

Main Methods:

• Literature review and synthesis of existing European studies on CDI costs.
• Analysis of resource consumption data where available.
• Comparative assessment of economic impacts across different CDI types.

Main Results:

• Healthcare facility-associated CDI incurs substantial costs in Europe.
• Recurrent, community-acquired, and pediatric CDI represent significant, less-explored economic burdens.
• Variability in cost estimations highlights the need for standardized methodologies.

Conclusions:

• CDI imposes a considerable economic burden on European healthcare systems.
• A broader assessment including recurrent, community-acquired, and pediatric CDI is necessary.
• Standardized methods are required for accurate and comparable economic burden assessments of CDI.